Virgin Galactic (NYSE: SPCE) surged 14% to $4.87 in midday trading, while Rocket Lab (NASDAQ: RKLB) climbed 6% to approximately $122 per share.
The moves appear tied to the ongoing SpaceX IPO roadshow, which is generating significant buzz across publicly traded space sector proxies.
According to Financial Times reporting, SpaceX’s IPO could raise up to $86 billion at a pitched valuation of $1.78 trillion, with Goldman Sachs serving as the lead investment bank.
The dynamic resembles a classic IPO halo trade, where heightened investor attention on a high-profile private company lifts sentiment in adjacent publicly listed names.
Prediction markets are pricing in near-certainty of a SpaceX listing, with Polymarket implying a 98.4% probability of an IPO by June 30 and a December 31 deadline trading near 99.4%.
SpaceX’s Form S-1 reveals the scale of the company, noting it has raised over $9 billion in equity capital since 2002, with its Connectivity segment generating $4,423 million in operating income and $7,168 million in Segment Adjusted EBITDA in 2025.
That kind of financial profile is drawing fresh capital flows into anything publicly labeled as a space company, with retail traders turning to SPCE and RKLB for accessible sector exposure.
Reddit activity reflects the enthusiasm, with an investing-subreddit thread asking “How do you think the SpaceX IPO will affect other space stocks (RKLB, ASTS, LUNR, etc.)?” becoming a primary driver of RKLB conversation this week.
Virgin Galactic’s gain is occurring against a challenging fundamental backdrop, with the company reporting Q1 2026 revenue of just $227,000 and a quarterly net loss of $65 million.
The longer-term picture for SPCE remains sobering, with the stock down 99% over five years despite a 93% rally over the past month.
CEO Michael Colglazier has stated the company remains on track to commence flight testing in Q3 and spaceflight in Q4 of this year, which represent the next tangible milestones for the pre-commercial operator.
Rocket Lab tells a considerably stronger business story, posting Q1 2026 revenue of $200 million, up 64% year over year, alongside a backlog of $2.2 billion.
CEO Peter Beck described the result as “another exceptional quarter with record financial performance of more than $200 million in revenue,” with the Neutron medium-lift rocket on track for a debut launch later in 2026.
RKLB shares have climbed 350% over the past year and 74% year to date, meaning today’s move carries both rebound and momentum characteristics.
The near-term catalyst calendar remains dense, with SpaceX potentially pricing as early as June 11 and a possible June 12 market debut under the ticker SPCX.
Whether today’s gains in SPCE and RKLB hold into the close, or fade once the SpaceX listing prints, will be a key signal for the durability of the broader space trade.
Beyond the IPO window, Rocket Lab’s Neutron debut and Virgin Galactic’s Q3 2026 flight-testing milestone represent the moments when IPO-driven enthusiasm could either align with, or diverge sharply from, underlying business fundamentals.
Both tickers remain speculative in nature, and investors may want to manage position sizing carefully around the SpaceX pricing window.
